SCHEMBL3813732

SCHEMBL3813732

COC1CN(c2nc(-c3cn(C)nn3)c(C(=O)O)s2)CCC1NC(=O)c1[nH]c(C)c(Cl)c1C#N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3399838 1.00 — —
SCHEMBL3402336 0.95 — —
SCHEMBL3399630 0.92 — —
SCHEMBL3405616 0.91 ABCC2 (0.51) —
SCHEMBL3402112 0.90 — —
SCHEMBL3402486 0.90 — —
SCHEMBL3403956 0.89 — —
SCHEMBL3400382 0.88 — —
SCHEMBL3400621 0.88 — —
SCHEMBL3800050 0.86 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2158199-A1 PIPERIDINE COMPOUNDS AND USES THEREOF AstraZeneca AB (SE) 2010-03-03 — — EP claimed
WO-2008152418-A1 PIPERIDINE COMPOUNDS AND USES THEREOF ASTRAZENECA AB (SE) 2008-12-18 — — WO claimed
Send feedback